Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term ox… Read more
Inogen Inc (INGN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.011x
Based on the latest financial reports, Inogen Inc (INGN) has a cash flow conversion efficiency ratio of 0.011x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.17 Million) by net assets ($197.18 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Inogen Inc - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Inogen Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Inogen Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inogen Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dorsel Holdings Ltd
TA:DRSH
|
0.011x |
|
IDUN INDUSTRIER AB B
F:1W6
|
N/A |
|
GFPT Public Company Limited
BK:GFPT
|
0.049x |
|
Trade-Van Information Services Co
TW:6183
|
0.038x |
|
JETEMA Co. Ltd
KQ:216080
|
0.061x |
|
Zippy Technology Corp
TW:2420
|
0.059x |
|
Fifth Era Acquisition Corp I Class A Ordinary Shares
NASDAQ:FERA
|
-0.001x |
|
Brazil Potash Corp.
NYSE:GRO
|
-0.015x |
Annual Cash Flow Conversion Efficiency for Inogen Inc (2011–2024)
The table below shows the annual cash flow conversion efficiency of Inogen Inc from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $173.86 Million | $5.91 Million | 0.034x | +315.43% |
| 2023-12-31 | $204.81 Million | $-3.23 Million | -0.016x | +87.49% |
| 2022-12-31 | $297.41 Million | $-37.53 Million | -0.126x | -297.70% |
| 2021-12-31 | $370.23 Million | $23.63 Million | 0.064x | -39.70% |
| 2020-12-31 | $349.62 Million | $37.01 Million | 0.106x | -10.12% |
| 2019-12-31 | $344.62 Million | $40.59 Million | 0.118x | -39.04% |
| 2018-12-31 | $310.42 Million | $59.98 Million | 0.193x | -27.49% |
| 2017-12-31 | $227.04 Million | $60.49 Million | 0.266x | +56.33% |
| 2016-12-31 | $182.09 Million | $31.03 Million | 0.170x | -40.15% |
| 2015-12-31 | $134.02 Million | $38.16 Million | 0.285x | +114.33% |
| 2014-12-31 | $118.15 Million | $15.70 Million | 0.133x | -44.46% |
| 2013-12-31 | $56.30 Million | $13.47 Million | 0.239x | +70.71% |
| 2012-12-31 | $28.57 Million | $4.00 Million | 0.140x | -43.05% |
| 2011-12-31 | $7.56 Million | $1.86 Million | 0.246x | -- |